相似文献
1
The impact of new drugs on management of glaucoma in Scotland: observational study.
BMJ. 2001 Dec 15;323(7326):1401-2. doi: 10.1136/bmj.323.7326.1401.
2
[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):275.
3
The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.
Br J Ophthalmol. 2002 May;86(5):551-4. doi: 10.1136/bjo.86.5.551.
4
Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017.
PLoS One. 2020 Jan 13;15(1):e0227595. doi: 10.1371/journal.pone.0227595. eCollection 2020.
5
Pharmacological advances in the treatment of glaucoma.
Drugs Aging. 1994 Sep;5(3):156-70. doi: 10.2165/00002512-199405030-00002.
6
New medical therapies in glaucoma management.
J Am Osteopath Assoc. 1997 Oct;97(10):582-3. doi: 10.7556/jaoa.1997.97.10.582.
7
[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
Ned Tijdschr Geneeskd. 1998 Sep 26;142(39):2138-41.
8
Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Can J Ophthalmol. 2015 Aug;50(4):297-301. doi: 10.1016/j.jcjo.2015.03.009.
9
[New drugs in glaucoma therapy].
Klin Monbl Augenheilkd. 1998 Jul;213(1):aA10-2.
10
Glaucoma prescribing trends in Australia and New Zealand.
Clin Exp Ophthalmol. 2006 Apr;34(3):213-8. doi: 10.1111/j.1442-9071.2006.01196.x.
引用本文的文献
1
Medical versus surgical interventions for open angle glaucoma.
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD004399. doi: 10.1002/14651858.CD004399.pub3.
2
The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.
Br J Ophthalmol. 2006 Jul;90(7):861-8. doi: 10.1136/bjo.2005.088666.
3
The rising cost of glaucoma drugs.
Br J Ophthalmol. 2006 Feb;90(2):130-1. doi: 10.1136/bjo.2005.079996.
4
Trends in ophthalmic surgery in Ireland.
Ir J Med Sci. 2005 Apr-Jun;174(2):36-9. doi: 10.1007/BF03169127.
5
Trabeculectomy and antimetabolites.
Br J Ophthalmol. 2004 Jul;88(7):855-6. doi: 10.1136/bjo.2004.040055.
6
Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study.
BMJ. 2002 Dec 14;325(7377):1396-7. doi: 10.1136/bmj.325.7377.1396.
7
The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.
Br J Ophthalmol. 2002 May;86(5):551-4. doi: 10.1136/bjo.86.5.551.
本文引用的文献
1
Models of open-angle glaucoma prevalence and incidence in the United States.
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):83-91.
2
Quality of Scottish Morbidity Record (SMR) data.
Health Bull (Edinb). 1996 Sep;54(5):410-7.
3
Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.
Ophthalmology. 1994 Oct;101(10):1651-6; discussion 1657. doi: 10.1016/s0161-6420(94)31120-1.
4
Referral patterns to an ophthalmic outpatient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease.
BMJ. 1988 Nov 5;297(6657):1162-7. doi: 10.1136/bmj.297.6657.1162.
Zotero 插件